Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy

scientific article

Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1050046323
P356DOI10.1186/S12937-015-0072-6
P932PMC publication ID4538921
P698PubMed publication ID26283663
P5875ResearchGate publication ID281141921

P50authorJordan E LakeQ98905399
Sandra Wagner CardosoQ117256309
Beatriz GrinsztejnQ60246105
Valdiléa G VelosoQ60637563
Risa HoffmanQ89630094
Judith S CurrierQ92484240
P2093author name stringPaula M Luz
Lara Coelho
Laura Mendonça
P2860cites workEvaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice GuidelineQ22306207
Update in vitamin DQ22306211
25-hydroxyvitamin D levels and the risk of mortality in the general populationQ24650811
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomesQ33997476
Cholecalciferol supplementation in HIV-infected youth with vitamin D insufficiency: effects on vitamin D status and T-cell phenotype: a randomized controlled trial.Q34340891
Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimenQ34403352
Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American womenQ35019046
Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settingsQ35154069
HDL cholesterol and bone mineral density: is there a genetic link?Q35608491
Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infectionQ36361380
A potential role for vitamin D on HIV infection?Q36505204
Interplay between vitamin D and the drug metabolizing enzyme CYP3A4Q36545257
Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults.Q36736469
Vitamin D in HIV-Infected PatientsQ36884537
Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000Q36906320
Risk factors for vitamin D deficiency and relationship with cardiac biomarkers, inflammation and immune restoration in HIV-infected youthQ37029416
Prevalence of vitamin D deficiency during the summer and its relationship with sun exposure and skin phototype in elderly men living in the tropicsQ37225445
Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular riskQ37324416
Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individualsQ37492503
Vitamin D status among healthy postmenopausal women in South AmericaQ37499904
Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trialQ37504465
Vitamin D insufficiency may impair CD4 recovery among Women's Interagency HIV Study participants with advanced disease on HAART.Q37518789
Less than adequate vitamin D status and intake in Latin America and the Caribbean:a problem of unknown magnitude.Q38114458
Correlation between 25-hydroxyvitamin D levels and latitude in Brazilian postmenopausal women: from the Arzoxifene Generations TrialQ38878333
HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D.Q40668951
Vitamin D supplementation is associated with reduced immune activation levels in HIV-1-infected patients on suppressive antiretroviral therapyQ41606828
Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral densityQ41684650
Association of vitamin D levels, lipid profile and intima media thickness in HIV positive patientsQ41968927
Factors associated with vitamin D deficiency in a population of 2044 HIV-infected patientsQ42262759
Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase.Q43001305
High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patientsQ43157193
1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.Q43775059
Bone mineral density, metabolic syndrome, and vitamin D in indigenous from south of BrazilQ44177746
Relation among micronutrient intakes with CD4 count in HIV infected patientsQ44270537
Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adultsQ44580359
High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs.Q44585706
Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbitalQ45117160
Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination SurveyQ45161552
Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasisQ45752853
Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survivalQ45783304
Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosisQ46042022
Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidismQ46101041
Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapyQ46543775
Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy.Q51678383
Correlation of Increases in 1,25-Dihydroxyvitamin D During Vitamin D Therapy With Activation of CD4+ T Lymphocytes in HIV-1–Infected MalesQ60291318
Prevalence and correlates of calcium and vitamin D status adequacy in adolescents, adults, and elderly from the Health Survey—São PauloQ61766893
Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59 degrees NQ80217296
P921main subjectcholecalciferolQ139347
anti-retroviral agentQ50430310
P304page(s)81
P577publication date2015-08-18
P1433published inNutrition JournalQ15751205
P1476titleVitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy
P478volume14

Reverse relations

cites work (P2860)
Q38844898Cholecalciferol 20 000 IU Once Weekly in HIV-Positive Patients with Low Vitamin D Levels: Result from a Cohort Study
Q54224147Continued Interest and Controversy: Vitamin D in HIV.
Q61798245Daily Nutritional Supplementation with Vitamin D₃ and Phenylbutyrate to Treatment-Naïve HIV Patients Tested in a Randomized Placebo-Controlled Trial
Q62489966Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial
Q38978858Effects of cholecalciferol supplementation on serum and urinary vitamin D metabolites and binding protein in HIV-infected youth
Q40112514Mechanisms of action of vitamin D as supplemental therapy for Pneumocystis pneumonia
Q33761301Micronutrient supplementation in adults with HIV infection.
Q58770234Monthly or Weekly Supplementation with Cholecalciferol 20,000 IU in People Living with HIV: Results from a Nested Cohort Study
Q40563423Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study
Q38610901Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer
Q90705218The Potential Protective Role of Vitamin D Supplementation on HIV-1 Infection
Q40375467The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease.
Q47159869Vitamin D Supplementation Does Not Affect Metabolic Changes Seen With ART Initiation
Q39026377Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor?
Q36816930Vitamin D and bone loss in HIV
Q55283531Vitamin D in Human Immunodeficiency Virus Infection: Influence on Immunity and Disease.
Q64235744Vitamin D in malaria: more hypotheses than clues
Q26746990Vitamin D-Regulated MicroRNAs: Are They Protective Factors against Dengue Virus Infection?
Q54574587[Vitamin D : More than just a bone hormone].

Search more.